Brazil approves marijuana derivative for medical treatment

January 14, 2015 byAdriana Gomez Licon
In this Dec. 18, 2014 file photo, relatives and friends of patients protest for the legalization of cannabidiol, a marijuana derivative that's banned in Brazil, outside the Health Surveillance Agency (ANVISA) in Brasilia, Brazil. On Wednesday, Jan. 14, 2015, for the first time Brazil approved the use of the marijuana derivative to treat people suffering from epilepsy, multiple sclerosis and schizophrenia among other disorders. (AP Photo/Eraldo Peres, File)

Brazil on Wednesday for the first time approved the use of a marijuana derivative to treat people suffering from severe seizures and other conditions.

Directors of the country's Health Surveillance Agency recognized the therapeutic properties of cannabidiol, saying it is now a "controlled" substance and no longer illegal.

It can now be used to treat epilepsy, multiple sclerosis and schizophrenia among other disorders.

Cannabidiol is not produced in Brazil and the agency said it will draw up legislation permitting it to be imported.

"We had a technical and scientific discussion of a matter that is often influenced by other issues and biases," the agency's president Jaime Oliveira told reporters.

He said cannabidiol does not cause dependency nor psychoactive effects on users.

"It is a great first step but we still need easier and less expensive access to the medication," said Margarete de Brito who gives cannabidiol to her 6-year-old daughter Sofia who was born with a genetic mutation that causes seizures.

Last month, the Federal Medical Council that regulates the medical profession in Brazil authorized neurologists and psychiatrists to prescribe cannabidiol to treat epileptic children and teenagers who do not respond to conventional treatment.

Explore further: Brazil to study legalization of medical marijuana

Related Stories

Brazil to study legalization of medical marijuana

December 19, 2014
Brazil will soon look into the possibility of legalizing the use of a marijuana derivative to treat people suffering from severe seizures.

Marijuana component could ease pain from chemotherapy drugs

October 6, 2011
A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy.

France seeks to stamp out first e-joint (Update)

December 16, 2014
France sought to stamp out a new electronic cigarette containing cannabis, launched Tuesday with the claim it provides all of the relaxation but none of the mind-altering effects of marijuana.

Could cannabis curb seizures? Experts weed through the evidence

May 22, 2014
The therapeutic potential of medical marijuana and pure cannabidiol (CBD), an active substance in the cannabis plant, for neurologic conditions is highly debated. A series of articles published in Epilepsia, a journal of ...

First cannabis-derived drug authorised for France

January 9, 2014
France has for the first time approved prescription use of a drug derived from cannabis—a mouth spray used to treat multiple sclerosis (MS) symptoms, the government said Thursday.

Recommended for you

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Introduction is different, but top medications for opioid addiction equally effective

November 14, 2017
With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.